238 related articles for article (PubMed ID: 15923622)
1. The HRPT2 tumor suppressor gene product parafibromin associates with human PAF1 and RNA polymerase II.
Yart A; Gstaiger M; Wirbelauer C; Pecnik M; Anastasiou D; Hess D; Krek W
Mol Cell Biol; 2005 Jun; 25(12):5052-60. PubMed ID: 15923622
[TBL] [Abstract][Full Text] [Related]
2. The parafibromin tumor suppressor protein is part of a human Paf1 complex.
Rozenblatt-Rosen O; Hughes CM; Nannepaga SJ; Shanmugam KS; Copeland TD; Guszczynski T; Resau JH; Meyerson M
Mol Cell Biol; 2005 Jan; 25(2):612-20. PubMed ID: 15632063
[TBL] [Abstract][Full Text] [Related]
3. Nuclear localization of the parafibromin tumor suppressor protein implicated in the hyperparathyroidism-jaw tumor syndrome enhances its proapoptotic function.
Lin L; Czapiga M; Nini L; Zhang JH; Simonds WF
Mol Cancer Res; 2007 Feb; 5(2):183-93. PubMed ID: 17314275
[TBL] [Abstract][Full Text] [Related]
4. Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin D1/PRAD1 expression.
Woodard GE; Lin L; Zhang JH; Agarwal SK; Marx SJ; Simonds WF
Oncogene; 2005 Feb; 24(7):1272-6. PubMed ID: 15580289
[TBL] [Abstract][Full Text] [Related]
5. The tumor suppressor parafibromin is required for posttranscriptional processing of histone mRNA.
Farber LJ; Kort EJ; Wang P; Chen J; Teh BT
Mol Carcinog; 2010 Mar; 49(3):215-23. PubMed ID: 19908240
[TBL] [Abstract][Full Text] [Related]
6. The parafibromin tumor suppressor protein inhibits cell proliferation by repression of the c-myc proto-oncogene.
Lin L; Zhang JH; Panicker LM; Simonds WF
Proc Natl Acad Sci U S A; 2008 Nov; 105(45):17420-5. PubMed ID: 18987311
[TBL] [Abstract][Full Text] [Related]
7. Identification of a functional bipartite nuclear localization signal in the tumor suppressor parafibromin.
Hahn MA; Marsh DJ
Oncogene; 2005 Sep; 24(41):6241-8. PubMed ID: 16116486
[TBL] [Abstract][Full Text] [Related]
8. A posttranscriptional role for the yeast Paf1-RNA polymerase II complex is revealed by identification of primary targets.
Penheiter KL; Washburn TM; Porter SE; Hoffman MG; Jaehning JA
Mol Cell; 2005 Oct; 20(2):213-23. PubMed ID: 16246724
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic analysis of Paf1/RNA polymerase II complex mutations reveals connections to cell cycle regulation, protein synthesis, and lipid and nucleic acid metabolism.
Betz JL; Chang M; Washburn TM; Porter SE; Mueller CL; Jaehning JA
Mol Genet Genomics; 2002 Oct; 268(2):272-85. PubMed ID: 12395202
[TBL] [Abstract][Full Text] [Related]
10. The Paf1 complex promotes displacement of histones upon rapid induction of transcription by RNA polymerase II.
Marton HA; Desiderio S
BMC Mol Biol; 2008 Jan; 9():4. PubMed ID: 18194564
[TBL] [Abstract][Full Text] [Related]
11. HRPT2, a tumor suppressor gene for hyperparathyroidism-jaw tumor syndrome.
Wang PF; Tan MH; Zhang C; Morreau H; Teh BT
Horm Metab Res; 2005 Jun; 37(6):380-3. PubMed ID: 16001331
[TBL] [Abstract][Full Text] [Related]
12. Loss of parafibromin expression in a subset of parathyroid adenomas.
Juhlin C; Larsson C; Yakoleva T; Leibiger I; Leibiger B; Alimov A; Weber G; Höög A; Villablanca A
Endocr Relat Cancer; 2006 Jun; 13(2):509-23. PubMed ID: 16728578
[TBL] [Abstract][Full Text] [Related]
13. Human RNA polymerase II-associated factor complex: dysregulation in cancer.
Chaudhary K; Deb S; Moniaux N; Ponnusamy MP; Batra SK
Oncogene; 2007 Nov; 26(54):7499-507. PubMed ID: 17599057
[TBL] [Abstract][Full Text] [Related]
14. Defective nucleolar localization and dominant interfering properties of a parafibromin L95P missense mutant causing the hyperparathyroidism-jaw tumor syndrome.
Panicker LM; Zhang JH; Dagur PK; Gastinger MJ; Simonds WF
Endocr Relat Cancer; 2010 Jun; 17(2):513-24. PubMed ID: 20304979
[TBL] [Abstract][Full Text] [Related]
15. Parafibromin inhibits cancer cell growth and causes G1 phase arrest.
Zhang C; Kong D; Tan MH; Pappas DL; Wang PF; Chen J; Farber L; Zhang N; Koo HM; Weinreich M; Williams BO; Teh BT
Biochem Biophys Res Commun; 2006 Nov; 350(1):17-24. PubMed ID: 16989776
[TBL] [Abstract][Full Text] [Related]
16. The Paf1 complex physically and functionally associates with transcription elongation factors in vivo.
Squazzo SL; Costa PJ; Lindstrom DL; Kumer KE; Simic R; Jennings JL; Link AJ; Arndt KM; Hartzog GA
EMBO J; 2002 Apr; 21(7):1764-74. PubMed ID: 11927560
[TBL] [Abstract][Full Text] [Related]
17. A Requirement for the Saccharomyces cerevisiae Paf1 complex in snoRNA 3' end formation.
Sheldon KE; Mauger DM; Arndt KM
Mol Cell; 2005 Oct; 20(2):225-36. PubMed ID: 16246725
[TBL] [Abstract][Full Text] [Related]
18. Direct interactions between the Paf1 complex and a cleavage and polyadenylation factor are revealed by dissociation of Paf1 from RNA polymerase II.
Nordick K; Hoffman MG; Betz JL; Jaehning JA
Eukaryot Cell; 2008 Jul; 7(7):1158-67. PubMed ID: 18469135
[TBL] [Abstract][Full Text] [Related]
19. CDC73/HRPT2 CpG island hypermethylation and mutation of 5'-untranslated sequence are uncommon mechanisms of silencing parafibromin in parathyroid tumors.
Hahn MA; Howell VM; Gill AJ; Clarkson A; Weaire-Buchanan G; Robinson BG; Delbridge L; Gimm O; Schmitt WD; Teh BT; Marsh DJ
Endocr Relat Cancer; 2010 Mar; 17(1):273-82. PubMed ID: 20026646
[TBL] [Abstract][Full Text] [Related]
20. Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias.
Gill AJ; Clarkson A; Gimm O; Keil J; Dralle H; Howell VM; Marsh DJ
Am J Surg Pathol; 2006 Sep; 30(9):1140-9. PubMed ID: 16931959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
